JP2023103368A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2023103368A5 JP2023103368A5 JP2023080507A JP2023080507A JP2023103368A5 JP 2023103368 A5 JP2023103368 A5 JP 2023103368A5 JP 2023080507 A JP2023080507 A JP 2023080507A JP 2023080507 A JP2023080507 A JP 2023080507A JP 2023103368 A5 JP2023103368 A5 JP 2023103368A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- cd40l
- composition
- loop
- specific monomeric
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562132198P | 2015-03-12 | 2015-03-12 | |
| US62/132,198 | 2015-03-12 | ||
| JP2021061713A JP7320550B2 (ja) | 2015-03-12 | 2021-03-31 | アルブミン融合タンパク質を精製する方法 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021061713A Division JP7320550B2 (ja) | 2015-03-12 | 2021-03-31 | アルブミン融合タンパク質を精製する方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023103368A JP2023103368A (ja) | 2023-07-26 |
| JP2023103368A5 true JP2023103368A5 (https=) | 2023-08-02 |
| JP7826243B2 JP7826243B2 (ja) | 2026-03-09 |
Family
ID=56878920
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017548053A Active JP6862348B2 (ja) | 2015-03-12 | 2016-03-11 | アルブミン融合タンパク質を精製する方法 |
| JP2021061713A Active JP7320550B2 (ja) | 2015-03-12 | 2021-03-31 | アルブミン融合タンパク質を精製する方法 |
| JP2023080507A Active JP7826243B2 (ja) | 2015-03-12 | 2023-05-16 | アルブミン融合タンパク質を精製する方法 |
Family Applications Before (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017548053A Active JP6862348B2 (ja) | 2015-03-12 | 2016-03-11 | アルブミン融合タンパク質を精製する方法 |
| JP2021061713A Active JP7320550B2 (ja) | 2015-03-12 | 2021-03-31 | アルブミン融合タンパク質を精製する方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (3) | US10683340B2 (https=) |
| EP (2) | EP3268389B1 (https=) |
| JP (3) | JP6862348B2 (https=) |
| KR (2) | KR20170124592A (https=) |
| CN (1) | CN107428817B (https=) |
| AU (4) | AU2016228806B2 (https=) |
| CA (2) | CA3260163A1 (https=) |
| ES (1) | ES2839211T3 (https=) |
| IL (1) | IL253971B (https=) |
| WO (1) | WO2016145307A1 (https=) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3753567A1 (en) | 2011-10-11 | 2020-12-23 | Viela Bio, Inc. | Cd40l-specific tn3-derived scaffolds and methods of use thereof |
| ES2991988T3 (es) | 2017-10-30 | 2024-12-05 | Takeda Pharmaceuticals Co | Detergentes compatibles con el medio ambiente para la inactivación de virus con envoltura lipídica |
| EA202092778A1 (ru) | 2018-05-16 | 2021-05-27 | ЛИБ ТЕРАПЬЮТИКС, ЭлЭлСи | Композиции, содержащие pcsk9-связывающие молекулы, и способы применения |
| CN113286806A (zh) * | 2018-11-09 | 2021-08-20 | 尼欧派普制药有限两合公司 | 治疗压力、免疫反应和中风综合征的多肽 |
| EP3711772A1 (en) | 2019-03-20 | 2020-09-23 | Oslo Universitetssykehus HF | Recombinant proteins and fusion proteins |
| CN110295152A (zh) * | 2019-07-29 | 2019-10-01 | 北京泓恩生物科技有限公司 | 一种重组产朊假丝酵母尿酸酶的纯化方法 |
| SG11202110968VA (en) | 2019-12-06 | 2021-10-28 | Regeneron Pharma | Anti-vegf protein compositions and methods for producing the same |
| AU2021268026A1 (en) | 2020-05-08 | 2023-01-19 | Regeneron Pharmaceuticals, Inc. | VEGF traps and mini-traps and methods for treating ocular disorders and cancer |
| JP2023532544A (ja) * | 2020-07-01 | 2023-07-28 | メディミューン，エルエルシー | 生物学的製剤を精製するための洗浄剤及び方法 |
| CN112062833A (zh) * | 2020-10-09 | 2020-12-11 | 国药集团武汉血液制品有限公司 | 一种从血浆组分ⅳ沉淀中提取人血白蛋白的方法 |
| CN115677848A (zh) * | 2022-10-24 | 2023-02-03 | 通化安睿特生物制药股份有限公司 | 一种制备高纯度高稳定性蛋白质的方法 |
Family Cites Families (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3101690B2 (ja) | 1987-03-18 | 2000-10-23 | エス・ビィ・２・インコーポレイテッド | 変性抗体の、または変性抗体に関する改良 |
| CA2079802C (en) | 1990-04-05 | 2001-09-18 | Roberto Crea | Walk-through mutagenesis |
| US7063943B1 (en) | 1990-07-10 | 2006-06-20 | Cambridge Antibody Technology | Methods for producing members of specific binding pairs |
| US5843701A (en) | 1990-08-02 | 1998-12-01 | Nexstar Pharmaceticals, Inc. | Systematic polypeptide evolution by reverse translation |
| US5866344A (en) | 1991-11-15 | 1999-02-02 | Board Of Regents, The University Of Texas System | Antibody selection methods using cell surface expressed libraries |
| FR2686899B1 (fr) * | 1992-01-31 | 1995-09-01 | Rhone Poulenc Rorer Sa | Nouveaux polypeptides biologiquement actifs, leur preparation et compositions pharmaceutiques les contenant. |
| US5440018A (en) * | 1992-05-20 | 1995-08-08 | The Green Cross Corporation | Recombinant human serum albumin, process for producing the same and pharmaceutical preparation containing the same |
| US5922545A (en) | 1993-10-29 | 1999-07-13 | Affymax Technologies N.V. | In vitro peptide and antibody display libraries |
| US5605793A (en) | 1994-02-17 | 1997-02-25 | Affymax Technologies N.V. | Methods for in vitro recombination |
| US6699658B1 (en) | 1996-05-31 | 2004-03-02 | Board Of Trustees Of The University Of Illinois | Yeast cell surface display of proteins and uses thereof |
| EP1958962A3 (en) | 1997-06-12 | 2013-05-01 | Novartis International Pharmaceutical Ltd. | Artificial antibody polypeptides |
| NZ511699A (en) | 1998-12-02 | 2003-02-28 | Phylos Inc | DNA-protein fusions and uses thereof |
| US6737056B1 (en) | 1999-01-15 | 2004-05-18 | Genentech, Inc. | Polypeptide variants with altered effector function |
| DK1196637T3 (da) | 1999-07-27 | 2007-07-30 | Adnexus Therapeutics Inc | Peptidacceptor-ligeringsmetoder |
| US7022479B2 (en) | 2000-01-24 | 2006-04-04 | Compound Therapeutics, Inc. | Sensitive, multiplexed diagnostic assays for protein analysis |
| AU2002310502A1 (en) | 2001-06-21 | 2003-01-08 | Phylos, Inc. | In vitro protein interaction detection systems |
| KR100524872B1 (ko) * | 2003-12-04 | 2005-11-01 | 씨제이 주식회사 | 인터페론 베타의 정제방법 |
| CA2572917C (en) | 2004-07-06 | 2012-04-03 | Bioren Inc. | Look-through mutagenesis for developing altered polypeptides with enhanced properties |
| CN101384623B (zh) | 2005-12-22 | 2013-07-24 | 常山凯捷健生物药物研发（河北）有限公司 | 白蛋白与治疗剂的预成型偶联物的制备方法 |
| KR101610791B1 (ko) | 2007-07-03 | 2016-04-11 | 다누타 크루셰프스카 | 알파케토글루타레이트의 의약 용도 |
| WO2009023184A2 (en) | 2007-08-10 | 2009-02-19 | Protelix, Inc. | Universal fibronectin type iii binding-domain libraries |
| US8633297B2 (en) | 2007-10-31 | 2014-01-21 | Medimmune, Llc | Protein scaffolds |
| ES2705714T3 (es) | 2008-10-31 | 2019-03-26 | Janssen Biotech Inc | Métodos y usos de dominio de Fibronectina tipo III basado en estructuras de composiciones |
| BRPI1008532B1 (pt) | 2009-02-12 | 2021-12-14 | Janssen Biotech, Inc | Arcabouço de proteína isolada, método para construção de uma biblioteca de arcabouço de proteína isolada, molécula de ácido nucleico isolada, vetor de ácido nucleico isolado, célula hospedeira de bactéria ou fungo, composição, dispositivo médico e artigo de manufatura para uso farmacêutico ou de diagnóstico em seres humanos |
| DK2427486T3 (en) | 2009-05-07 | 2015-05-26 | Novozymes Biopharma Dk As | A process for purifying albumin |
| EP2493921B1 (en) | 2009-10-30 | 2018-09-26 | Albumedix Ltd | Albumin variants |
| KR20130020765A (ko) | 2010-02-16 | 2013-02-28 | 메디뮨 엘엘씨 | Ｈｓａ-관련 조성물 및 사용방법 |
| WO2011130324A1 (en) | 2010-04-13 | 2011-10-20 | Medimmune, Llc | Fibronectin type iii domain-based multimeric scaffolds |
| CN103379915A (zh) | 2011-02-15 | 2013-10-30 | 米迪缪尼有限公司 | Hsa相关组合物及使用方法 |
| EP3753567A1 (en) | 2011-10-11 | 2020-12-23 | Viela Bio, Inc. | Cd40l-specific tn3-derived scaffolds and methods of use thereof |
| MX2015005363A (es) * | 2012-11-08 | 2015-11-06 | Novozymes Biopharma Dk As | Variantes de albumina. |
-
2016
- 2016-03-11 AU AU2016228806A patent/AU2016228806B2/en active Active
- 2016-03-11 EP EP16762595.3A patent/EP3268389B1/en active Active
- 2016-03-11 KR KR1020177028780A patent/KR20170124592A/ko not_active Ceased
- 2016-03-11 CA CA3260163A patent/CA3260163A1/en active Pending
- 2016-03-11 ES ES16762595T patent/ES2839211T3/es active Active
- 2016-03-11 KR KR1020247016329A patent/KR20240093725A/ko active Pending
- 2016-03-11 CA CA2977675A patent/CA2977675A1/en active Pending
- 2016-03-11 CN CN201680014597.2A patent/CN107428817B/zh active Active
- 2016-03-11 WO PCT/US2016/022003 patent/WO2016145307A1/en not_active Ceased
- 2016-03-11 US US15/557,358 patent/US10683340B2/en active Active
- 2016-03-11 EP EP20198757.5A patent/EP3842451A1/en active Pending
- 2016-03-11 JP JP2017548053A patent/JP6862348B2/ja active Active
-
2017
- 2017-08-14 IL IL253971A patent/IL253971B/en unknown
-
2020
- 2020-06-15 US US16/901,812 patent/US11548933B2/en active Active
-
2021
- 2021-01-22 AU AU2021200423A patent/AU2021200423B2/en active Active
- 2021-03-31 JP JP2021061713A patent/JP7320550B2/ja active Active
-
2023
- 2023-01-06 US US18/150,983 patent/US20230340074A1/en active Pending
- 2023-05-16 JP JP2023080507A patent/JP7826243B2/ja active Active
- 2023-07-03 AU AU2023204271A patent/AU2023204271B2/en active Active
-
2026
- 2026-03-13 AU AU2026201911A patent/AU2026201911A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023103368A5 (https=) | ||
| JP7724814B2 (ja) | Ｈｉｖ感染症の予防または処置のための三重特異性および／または三価結合タンパク質 | |
| CN107223135B (zh) | 用于治疗hbv感染和相关病症的三特异性结合分子 | |
| JP2022543387A5 (https=) | ||
| CN113728005B (zh) | Cd3特异性结合分子 | |
| AU2009201260B2 (en) | Peptide-based passive immunization therapy for treatment of atherosclerosis | |
| WO2020163646A1 (en) | Anti-gitr antigen-binding domains and uses thereof | |
| CN105531370A (zh) | 治疗靶向特异性vnar结构域与icosl的分离 | |
| JP2021508449A5 (https=) | ||
| WO1993011162A1 (en) | Bispecific antibody heterodimers | |
| JP2010518854A5 (https=) | ||
| JP2025512865A5 (https=) | ||
| JP2023553694A5 (https=) | ||
| FI3999119T3 (fi) | Muokattuja aav-kapsidiproteiineja niveltulehdussairauden hoitoon | |
| JP2024544559A5 (https=) | ||
| JP2022540918A5 (https=) | ||
| JP2022541761A5 (https=) | ||
| JP2022513321A5 (https=) | ||
| CN103930128A (zh) | 组成型活性uPAR变体及其在抑制性抗体的生成与分离中的应用 | |
| WO2006046661A1 (ja) | インターロイキン－６阻害剤 | |
| AU2003267905B2 (en) | Peptide-based passive immunization therapy for treatment of atherosclerosis | |
| CN113874393A (zh) | 对hbv包膜蛋白具有特异性的结合分子 | |
| JP2024546916A5 (https=) | ||
| CN120112558A (zh) | 治疗慢性病毒感染的含cd8抗原结合分子的融合物 | |
| WO2024017281A1 (zh) | 多特异性抗体及其用途 |